High- or very-high risk, localized or locally advanced prostate cancer
Conditions
Brief summary
MFS is defined as the time from randomization to the date of the first occurrence of radiographic bone or soft tissue distant metastasis based on conventional imaging assesed by BICR, histopathologic diagnosis of distant metastasis, or death from any cause, whichever occurs first.
Interventions
Sponsors
Janssen - Cilag International
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MFS is defined as the time from randomization to the date of the first occurrence of radiographic bone or soft tissue distant metastasis based on conventional imaging assesed by BICR, histopathologic diagnosis of distant metastasis, or death from any cause, whichever occurs first. | — |
Countries
Belgium, Czechia, France, Germany, Italy, Poland, Romania, Spain, Sweden
Outcome results
None listed